Comparison of Elution Swab (ESwab) and Amies Transport Swabs for Screening Patients for Methicillin Resistant Staphylococcus Aureus (MRSA) and Vancomycin Resistant Enterococci (VRE) Colonization (MRSA VRE)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00941122 |
Recruitment Status
:
Completed
First Posted
: July 17, 2009
Last Update Posted
: July 20, 2011
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Eluted Swab | Device: Eluted Swab |
Study Type : | Observational |
Actual Enrollment : | 30 participants |
Time Perspective: | Prospective |
Official Title: | Comparison of Elution Swab (ESwab) and Amies Transport Swabs for Screening Patients for Methicillin Resistant Staphylococcus Aureus (MRSA) and Vancomycin Resistant Enterococci (VRE) Colonization |
Study Start Date : | July 2009 |
Actual Primary Completion Date : | January 2011 |
Actual Study Completion Date : | March 2011 |

Group/Cohort | Intervention/treatment |
---|---|
MRSA/VRE patients
patients known to be colonized with MRSA/VRE
|
Device: Eluted Swab
Comparison of Eluted Swab with AMIES swab for detection of MRSA/VRE
|
- 1. To assess whether the Elution swab (ESwab) is superior to Amies transport swabs for the detection of MRSA/VRE [ Time Frame: 12 months ]
- 1. To assess whether the Elution swab (ESwab) is superior to Amies transport swabs for the detection of MRSA/VRE in colonized patients [ Time Frame: 12 months ]
- To assess patient comfort in the use of the ESwab vs. Amies Transport swab for screening patients for methicillin resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. [ Time Frame: 12 months ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Senior |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Hospitallized patients known to be colonized with MRSA/VRE
Exclusion Criteria:
- Unable to provide informed consent

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00941122
Canada, Ontario | |
St. Joseph's Healthcare | |
Hamilton, Ontario, Canada, L8N 4A6 |
Principal Investigator: | Christine Lee, MD | McMaster University |
Responsible Party: | Christine Lee, McMaster University |
ClinicalTrials.gov Identifier: | NCT00941122 History of Changes |
Other Study ID Numbers: |
MRSA.VRE.Detection |
First Posted: | July 17, 2009 Key Record Dates |
Last Update Posted: | July 20, 2011 |
Last Verified: | July 2011 |
Keywords provided by McMaster University:
MRSA, VRE |
Additional relevant MeSH terms:
Staphylococcal Infections Gram-Positive Bacterial Infections Bacterial Infections Vancomycin |
Methicillin Anti-Bacterial Agents Anti-Infective Agents |